Cargando…

The hybrid approach for the surgical treatment of lone atrial fibrillation: One-year results employing a monopolar radiofrequency source

BACKGROUND: The hybrid technique combines a mono or bilateral epicardial approach with a percutaneous endocardial ablation in a single-step procedure. We present our early results with this technique employing a monopolar radiofrequency source through a right thoracoscopy in patients with lone atria...

Descripción completa

Detalles Bibliográficos
Autores principales: La Meir, Mark, Gelsomino, Sandro, Lorusso, Roberto, Lucà, Fabiana, Pison, Laurant, Parise, Orlando, Wellens, Francis, Gensini, Gian Franco, Maessen, Jos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432010/
https://www.ncbi.nlm.nih.gov/pubmed/22812613
http://dx.doi.org/10.1186/1749-8090-7-71
_version_ 1782242148254482432
author La Meir, Mark
Gelsomino, Sandro
Lorusso, Roberto
Lucà, Fabiana
Pison, Laurant
Parise, Orlando
Wellens, Francis
Gensini, Gian Franco
Maessen, Jos
author_facet La Meir, Mark
Gelsomino, Sandro
Lorusso, Roberto
Lucà, Fabiana
Pison, Laurant
Parise, Orlando
Wellens, Francis
Gensini, Gian Franco
Maessen, Jos
author_sort La Meir, Mark
collection PubMed
description BACKGROUND: The hybrid technique combines a mono or bilateral epicardial approach with a percutaneous endocardial ablation in a single-step procedure. We present our early results with this technique employing a monopolar radiofrequency source through a right thoracoscopy in patients with lone atrial fibrillation (LAF). METHODS: Between June 2009 and December 2010 nineteen consecutive patients (mean 60.8 ± 8.6 years, 84.2% male) underwent right unilateral minimally invasive hybrid procedure for LAF at our Institution. Ten patients (52.6.6%) had long-standing persistent AF while four (21.1%) had persistent and five (26.3%) paroxysmal AF. All patients were followed-up according the Heart Rhythm Society/European Heart Rhythm Association/European Cardiac Arrhythmia Society (HRS/EHRA/ECA) and Society of Thoracic Surgeon (STS) guidelines. RESULTS: There were neither early nor late deaths. It was possible to complete all the procedures as planned without any conversion to cardiopulmonary bypass. No patient died during the follow up. At one year, 7/19 (36.8%) patients were in sinus rhythm with no episode of AF and off antiarrhythmic drugs (AAD). Time-related prevalence of postoperative AF peaked at 44.4% (41.3–47.4) at two weeks, was 30.4% (27.3–34.9) at three months, fell to 14.2% (11.6–18.1) by 6 months and was 13.3% (11.0–17.4) at 12 months Among patients with long-standing persistent (LSP) AF, 20% (2/10) were in Sinus rythm and off AAD. One-year success rates were 50% (2/4) in persistent and 60% (3/5) in paroxysmal AF. At 12 months estimated prevalence of antyarrhythmic drugs and Warfarin use were 26% (22.4–33.1) and 48% (37.2–53.2), respectively. CONCLUSIONS: One year results combining the percutaneous endocardial with the right thoracoscopic epicardial technique were, in our experience, not satisfactory, particularly in patients with LSP and persistent AF. Our findings need to be confirmed by larger studies.
format Online
Article
Text
id pubmed-3432010
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34320102012-09-01 The hybrid approach for the surgical treatment of lone atrial fibrillation: One-year results employing a monopolar radiofrequency source La Meir, Mark Gelsomino, Sandro Lorusso, Roberto Lucà, Fabiana Pison, Laurant Parise, Orlando Wellens, Francis Gensini, Gian Franco Maessen, Jos J Cardiothorac Surg Research Article BACKGROUND: The hybrid technique combines a mono or bilateral epicardial approach with a percutaneous endocardial ablation in a single-step procedure. We present our early results with this technique employing a monopolar radiofrequency source through a right thoracoscopy in patients with lone atrial fibrillation (LAF). METHODS: Between June 2009 and December 2010 nineteen consecutive patients (mean 60.8 ± 8.6 years, 84.2% male) underwent right unilateral minimally invasive hybrid procedure for LAF at our Institution. Ten patients (52.6.6%) had long-standing persistent AF while four (21.1%) had persistent and five (26.3%) paroxysmal AF. All patients were followed-up according the Heart Rhythm Society/European Heart Rhythm Association/European Cardiac Arrhythmia Society (HRS/EHRA/ECA) and Society of Thoracic Surgeon (STS) guidelines. RESULTS: There were neither early nor late deaths. It was possible to complete all the procedures as planned without any conversion to cardiopulmonary bypass. No patient died during the follow up. At one year, 7/19 (36.8%) patients were in sinus rhythm with no episode of AF and off antiarrhythmic drugs (AAD). Time-related prevalence of postoperative AF peaked at 44.4% (41.3–47.4) at two weeks, was 30.4% (27.3–34.9) at three months, fell to 14.2% (11.6–18.1) by 6 months and was 13.3% (11.0–17.4) at 12 months Among patients with long-standing persistent (LSP) AF, 20% (2/10) were in Sinus rythm and off AAD. One-year success rates were 50% (2/4) in persistent and 60% (3/5) in paroxysmal AF. At 12 months estimated prevalence of antyarrhythmic drugs and Warfarin use were 26% (22.4–33.1) and 48% (37.2–53.2), respectively. CONCLUSIONS: One year results combining the percutaneous endocardial with the right thoracoscopic epicardial technique were, in our experience, not satisfactory, particularly in patients with LSP and persistent AF. Our findings need to be confirmed by larger studies. BioMed Central 2012-07-19 /pmc/articles/PMC3432010/ /pubmed/22812613 http://dx.doi.org/10.1186/1749-8090-7-71 Text en Copyright ©2012 La Meir et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
La Meir, Mark
Gelsomino, Sandro
Lorusso, Roberto
Lucà, Fabiana
Pison, Laurant
Parise, Orlando
Wellens, Francis
Gensini, Gian Franco
Maessen, Jos
The hybrid approach for the surgical treatment of lone atrial fibrillation: One-year results employing a monopolar radiofrequency source
title The hybrid approach for the surgical treatment of lone atrial fibrillation: One-year results employing a monopolar radiofrequency source
title_full The hybrid approach for the surgical treatment of lone atrial fibrillation: One-year results employing a monopolar radiofrequency source
title_fullStr The hybrid approach for the surgical treatment of lone atrial fibrillation: One-year results employing a monopolar radiofrequency source
title_full_unstemmed The hybrid approach for the surgical treatment of lone atrial fibrillation: One-year results employing a monopolar radiofrequency source
title_short The hybrid approach for the surgical treatment of lone atrial fibrillation: One-year results employing a monopolar radiofrequency source
title_sort hybrid approach for the surgical treatment of lone atrial fibrillation: one-year results employing a monopolar radiofrequency source
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432010/
https://www.ncbi.nlm.nih.gov/pubmed/22812613
http://dx.doi.org/10.1186/1749-8090-7-71
work_keys_str_mv AT lameirmark thehybridapproachforthesurgicaltreatmentofloneatrialfibrillationoneyearresultsemployingamonopolarradiofrequencysource
AT gelsominosandro thehybridapproachforthesurgicaltreatmentofloneatrialfibrillationoneyearresultsemployingamonopolarradiofrequencysource
AT lorussoroberto thehybridapproachforthesurgicaltreatmentofloneatrialfibrillationoneyearresultsemployingamonopolarradiofrequencysource
AT lucafabiana thehybridapproachforthesurgicaltreatmentofloneatrialfibrillationoneyearresultsemployingamonopolarradiofrequencysource
AT pisonlaurant thehybridapproachforthesurgicaltreatmentofloneatrialfibrillationoneyearresultsemployingamonopolarradiofrequencysource
AT pariseorlando thehybridapproachforthesurgicaltreatmentofloneatrialfibrillationoneyearresultsemployingamonopolarradiofrequencysource
AT wellensfrancis thehybridapproachforthesurgicaltreatmentofloneatrialfibrillationoneyearresultsemployingamonopolarradiofrequencysource
AT gensinigianfranco thehybridapproachforthesurgicaltreatmentofloneatrialfibrillationoneyearresultsemployingamonopolarradiofrequencysource
AT maessenjos thehybridapproachforthesurgicaltreatmentofloneatrialfibrillationoneyearresultsemployingamonopolarradiofrequencysource
AT lameirmark hybridapproachforthesurgicaltreatmentofloneatrialfibrillationoneyearresultsemployingamonopolarradiofrequencysource
AT gelsominosandro hybridapproachforthesurgicaltreatmentofloneatrialfibrillationoneyearresultsemployingamonopolarradiofrequencysource
AT lorussoroberto hybridapproachforthesurgicaltreatmentofloneatrialfibrillationoneyearresultsemployingamonopolarradiofrequencysource
AT lucafabiana hybridapproachforthesurgicaltreatmentofloneatrialfibrillationoneyearresultsemployingamonopolarradiofrequencysource
AT pisonlaurant hybridapproachforthesurgicaltreatmentofloneatrialfibrillationoneyearresultsemployingamonopolarradiofrequencysource
AT pariseorlando hybridapproachforthesurgicaltreatmentofloneatrialfibrillationoneyearresultsemployingamonopolarradiofrequencysource
AT wellensfrancis hybridapproachforthesurgicaltreatmentofloneatrialfibrillationoneyearresultsemployingamonopolarradiofrequencysource
AT gensinigianfranco hybridapproachforthesurgicaltreatmentofloneatrialfibrillationoneyearresultsemployingamonopolarradiofrequencysource
AT maessenjos hybridapproachforthesurgicaltreatmentofloneatrialfibrillationoneyearresultsemployingamonopolarradiofrequencysource